SOMNI7
Food supplement declared in France, declaration No 2021-11-120
SOMNI7 is a food supplement declared in France. Status: retrait du marché annoncé pour le 22 June 2029. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- New Stefal Holding
- Status
- Retrait du marché annoncé pour le 22 June 2029
- Form
- Comprimé
- Daily dose
- 2 comprimés
- Directions for use
- Prendre deux comprimés le soir avec un verre d'eau.
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Femmes enceintes
- Objectives stated by the manufacturer (these are not authorised claims)
- Sommeil
Declaration 179894, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 22 June 2029, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Passiflora incarnata L. | Parties aériennes | Extrait sec aqueux | 375 mg |
| Melissa officinalis L. | Feuille | Extrait sec aqueux | 150 mg |
| Crataegus laevigata (Poir.) DC. | Sommités fleuries | Poudre (de plantes séchées ou broyées) | 100 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Mélatonine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Oxyde de magnésium | Magnésium | 250 mg | 300 mg |
| Chlorhydrate de thiamine | Vitamine B1 (thiamine) | pas de limite (données insuffisantes) | dose annulée par le Conseil d'État en 2011 |
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
Additives
E414, E460, E470b
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Les compléments alimentaires doivent être utilisés dans le cadre d'un mode de vie sain et ne peuvent être utilisés comme substituts d'un régime alimentaire varié et équilibré. Ne pas dépasser la dose journalière recommandée. L'effet bénéfique est obtenu par la consommation de 1mg de mélatonine avant le coucher. Ne convient pas aux femmes enceintes ou qui allaitent. Tenir hors de portée des jeunes enfants. A conserver au frais, au sec et à l'abri de la lumière.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.